A report released by the World Economic Forum in collaboration with the Boston Consulting Group highlighted that women's health received only 6% of all private investments in the sector from 2020 to 2025. This funding amounts to approximately $175 billion out of a total of $2.87 trillion in private health sector investment during these five years. Most of the funding is directed towards women's cancers, reproductive health, and maternal health, leaving many other conditions underfunded.

The report reveals that 90% of the private investment is concentrated in just three areas, while significant health issues like cardiovascular diseases, osteoporosis, menopause, and Alzheimer's suffer from a lack of adequate funding, particularly in low- and middle-income countries. These countries are disproportionately affected by this gap, indicating a troubling trend in health equity.

Furthermore, specific women's health conditions, such as menopause, endometriosis, polycystic ovary syndrome, and menstrual health collectively receive less than 2% of the total identified funding for women's health. This underinvestment highlights critical areas of need that require urgent attention and funding to ensure comprehensive healthcare for women globally.